BHST - BioHarvest Sciences Forvard P/S multiplikatori
Biosintezni kengaytirish xavflari va Yevropa Ittifoqining tartibga soluvchi to'siqlari BioHarvest Sciences (BHST) kompaniyasiga o'rtacha bosim o'tkazmoqda. GURU.Markets platformasida, kelajakdagi sotuvlarga nisbatan narx ko'rsatkichi grafigi qiymat 1.00 darajasida barqarorlashgan narx vektorini namoyish etadi. Biznesning fundamental asoslari tuproksiz hujayralarni yetishtirish tozaligiga tayanadi, nutratsevtikalarga bo'lgan barqaror talab esa aksiyaning makroiqtisodiy sikllarga bog'liqligini minimallashtiradi.
BioHarvest Sciences Inc (BHST) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi statistikasi:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati BioHarvest Sciences|BHST - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati BioHarvest Sciences|BHST - Jamlangan qarz majburiyatlari|Qarzning balans qiymatiga nisbati BioHarvest Sciences Inc|BHST - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari BioHarvest Sciences|Tezkor likvidlik bioharvest.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
BHST - Sof moliyaviy natija|Kelajakdagi foyda BioHarvest Sciences|BHST - Bozor narxining sof foydaga nisbati|Prognoz qilingan narxning foydaga nisbati BioHarvest|BHST - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati BioHarvest Sciences Inc|BHST - Amortizatsiya chegirilmasdan oldingi operatsion daromad|Bir aksiya uchun sof foyda (EPS TTM) BioHarvest Sciences|BHST - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi bioharvest.com|BHST - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi BioHarvest Sciences
- tushum va sotuvlar tafsilotlari:
Kompaniyaning jamlanma tahlili:BioHarvest Sciences Inc. (BHST)
BioHarvest Sciences (BHST) hujayraviy bio-o'sish orqali qishloq xo'jaligi sektorini transformatsiya qilmoqda, bunda kutilayotgan daromad koeffitsienti bioreaktor quvvatlarini kengaytirish samaradorligining asosiy ko'rsatkichi hisoblanadi. Ushbu metrika joriy bozor qiymatini prognoz qilingan daromad bilan bog'laydi, bu esa resurslarni optimallashtirish rejalari va sotuvlarni kengaytirish sur'atlaridan chetga chiqish yuz bergan taqdirda, aktivlarning haddan tashqari yuqori baholanishi xavfini baholash imkonini beradi.
BioHarvest Sciences kimlar bilan raqobatlashadi
Forvard P/S multiplikatori HLN (Haleon)|Kenvue Inc - Narxning prognoz qilingan daromadga nisbati|Verona Pharma Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Jyong Bio MENS|Ligand Pharmaceuticals (LGND) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati amneal.com (AMRX)|PRGO (Perrigo) - Forvard P/S multiplikatori|ALVO: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori LQDA|Forvard P/S multiplikatori Galapagos Corp (GLPG)|Narxning prognoz qilingan daromadga nisbati ANI Pharmaceuticals ANIP|Sotuvga nisbatan forvard narx MNKD|AMPH: Forvard narx/daromad multiplikatori|PCRX: Narxning prognoz qilingan daromadga nisbati|SPRY: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Theravance Corp (TBPH)|Narxning prognoz qilingan daromadga nisbati Aquestive Therapeutics|scPharma (SCPH) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori TECX (Tectonic Therapeutic, Inc.)|Narxning kutilayotgan daromadga nisbati TNXP|China SXT Pharmaceuticals, Inc. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx EPRX|EXOZ - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Oramed Pharmaceuticals ORMP|ENTX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori MindWalk Holdings, Inc.|ABVC (ABVC BioPharma Inc) - Forvard P/S multiplikatori|Cumberland Corp (CPIX) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori QNTM|FGEN - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Telomir Pharmaceuticals, Inc. TELO|RANI: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Synergy CHC Corporation - Forvard P/S multiplikatori|Rallybio Corporation (RLYB) - Forvard narx/daromad multiplikatori|LEXX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati pulmatrix.com (PULM)|Narxning prognoz qilingan daromadga nisbati Pheton Holdings Limited|Aptorum (APM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori LYRA|Narxning prognoz qilingan daromadga nisbati IBO (Impact BioMedical, Inc.)|Forvard P/S multiplikatori TNFA (TNF Pharmaceuticals, Inc.)|Sotuvga nisbatan forvard narx YCBD|PRFX - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Altamira Therapeutics CYTO|LIPO (Lipella) - Forvard narx/daromad multiplikatori|OPTN: Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals|procapsgroup.com - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori PTPI|QLI (Qilian International Holding Group) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori SLRN (ACELYRIN, Inc.)|Forvard P/S multiplikatori TFF Pharmaceuticals, Inc TFFP
